Assessing human cardiac allograft rejection using MRI with Gd-DOTA

Area of Science:

• Cardiovascular Imaging
• Transplant Medicine
• Radiology

Background:

• Cardiac allograft rejection is a significant complication after heart transplantation.
• Accurate and non-invasive detection of rejection is crucial for patient management.
• Gadolinium tetraazacyclododecane tetraacetic acid (Gd-DOTA) is a contrast agent used in MRI.

Purpose of the Study:

• To evaluate the efficacy of MRI using Gd-DOTA for detecting cardiac allograft rejection.
• To correlate quantitative myocardial enhancement (ME) with histological findings of rejection.
• To determine if regional or mean ME is a better indicator of early rejection.

Main Methods:

• MRI was performed on 7 healthy volunteers and 39 heart transplant recipients.
• Patients were categorized into three groups based on histological rejection severity (none, grade 1, grade 2-3).
• Quantitative myocardial enhancement (ME) was measured regionally and as a mean after Gd-DOTA administration.

Main Results:

• Myocardial enhancement was significantly higher in patients with grade 1 and grade 2-3 rejection compared to those without rejection.
• Regional ME showed a better ability to distinguish focal histological changes in early rejection.
• No significant difference in ME was observed between grade 1 and grade 2-3 rejection groups.

Conclusions:

• MRI with Gd-DOTA can detect cardiac allograft rejection.
• Regional ME appears more sensitive than mean ME for identifying early rejection.
• Further software development is needed to precisely correlate ME with edema and rejection severity.